Hi Dear Daniel

Please search diabet in this link

http://www.citefactor.org/journal-impact-factor-list-2014.html

for example:

Acta Diabetologica 0940-5429 3.679 4.631 2.784 3.175 1.549 0.926

Hi, Daniel,

Journal of Diabetes is now indexed by Thomson Reuters SCIE and MEDLINE!

2013 Impact Factor Now Released - 2.349!

Yingyun Gong

http://mc.manuscriptcentral.com/jdb

Hi Dear Daniel

Please search diabet in this link

http://www.citefactor.org/journal-impact-factor-list-2014.html

for example:

Acta Diabetologica 0940-5429 3.679 4.631 2.784 3.175 1.549 0.926

According to 2013 JCR, the Journal of Diabetes Research has not yet received any impact factor yet. Please see the attached document.

3.536 according to journal web page!! how to get full list of impact factor for journals according to Thomson reuters?

Leto 2013

Naslov revije Journal of Diabetes Research

ISSN 2314-6745

Država izdaje USA

Kategorija SE IA - endocrinology & metabolism ; 122/123 ; četrtina: 4 ; x=3.354 ; IFmin: 0 ; IFmax: 1.603

QA - medicine, research & experimental ; 121/122 ; četrtina: 4 ; x=3.129 ; IFmin: 0.171 ; IFmax: 1.152

Victor C. Kok is correct. No impact factor yet per JCR 2013.

Indeed Victor C. Kok is correct.

Dear Daniel,

According to Kobson Serbia list this journal doesn't have impact factor yet.

Please see attached file.

Wish you all the best,

Olga 

According to the website, I can read this: The most recent Impact Factor for Experimental Diabetes Research is 3.536 according to 2013 Journal Citation Reports released by Thomson Reuters in 2014.

Journal of Diabetes Research Yong not Experimental Diabetes Research

It seems as Journal of Diabetes Research and Experimental Diabetes Research are two different journals (different ISSN) with different IF (according to Thompson Reuters).

Experimental Diabetes Research has  IF 3.536 according to 2013 Journal Citation Reports released by Thomson Reuters in 2014), and  Journal of Diabetes Research  has no IF according to 2013 Journal Citation Reports released by Thomson Reuters in 2014. 

It seems that things are getting more clear to me.

What would be optimat protection agains GI bleeding after dual antiplatelet Therapy (clopidogrel + aspirin) after coronary stenting with DES stents?

Should pantoprazol in optimal dose  be enough?

Can anyone tell me whether the impact factor of Journal of diabetes research (Formerly known as experimental diabetes research) has been degraded from 3.536 (2013) to 2.164 (2014)

Yes, it downgraded to 2.164 (confirmed at Journal Citation ReportsTM, Thomson Reuters)

It is 2.164 as per latest JCR report by Thomson Reuters.